Predictors of Stability/Improvement of Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis After One Year of Treatment With Nintedanib

被引：1
|
作者：
Mondoni, Michele [1 ]
Varone, Francesco [2 ]
Alfano, Fausta [1 ]
Muscato, Giuseppe [3 ]
Conti, Caterina [4 ]
Saderi, Laura [6 ]
Iovene, Bruno [2 ]
Di Marco, Fabiano [4 ,5 ]
Vancheri, Carlo [3 ]
Richeldi, Luca [2 ]
Centanni, Stefano [1 ]
Sotgiu, Giovanni [6 ]
机构：
[1] Univ Milan, Dept Hlth Sci, ASST Santi Paolo & Carlo, Resp Unit, Milan, Italy
[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Div Pulm Med, Rome, Italy
[3] Univ Catania, Reg Referral Ctr Rare Lung Dis, AOU Policlin San Marco, Dept Clin & Expt Med, Catania, Italy
[4] ASST Papa Giovanni XXIII, Resp Unit, Bergamo, Italy
[5] Univ Milan, Dept Hlth Sci, Milan, Italy
[6] Univ Sassari, Dept Med Surg & Expt Sci, Clin Epidemiol & Med Stat Unit, Sassari, Italy
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2023年 / 59卷 / 07期
关键词：
D O I：
10.1016/j.arbres.2023.02.010
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：464 / 466
页数：3
相关论文
共 50 条
  • [21] Predictors of Mortality in Idiopathic Pulmonary Fibrosis: Forced Vital Capacity Decline and Other Surrogate Endpoints - A Literature Review
    Baldwin, M.
    Langham, S.
    Patel, N.
    Pooley, N.
    Ortega, P. Rivera
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [22] Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
    Santermans, Eva
    Ford, Paul
    Kreuter, Michael
    Verbruggen, Nadia
    Meyvisch, Paul
    Wuyts, Wim A.
    Brown, Kevin K.
    Lederer, David J.
    Byrne, Adam J.
    Molyneaux, Philip L.
    Sivananthan, Arunon
    Moor, Catharina C.
    Maher, Toby M.
    Wijsenbeek, Marlies
    ADVANCES IN THERAPY, 2019, 36 (11) : 3059 - 3070
  • [23] Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
    Eva Santermans
    Paul Ford
    Michael Kreuter
    Nadia Verbruggen
    Paul Meyvisch
    Wim A. Wuyts
    Kevin K. Brown
    David J. Lederer
    Adam J. Byrne
    Philip L. Molyneaux
    Arunon Sivananthan
    Catharina C. Moor
    Toby M. Maher
    Marlies Wijsenbeek
    Advances in Therapy, 2019, 36 : 3059 - 3070
  • [24] Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
    Richeldi, Luca
    Ryerson, Christopher J.
    Lee, Joyce S.
    Wolters, Paul J.
    Koth, Laura L.
    Ley, Brett
    Elicker, Brett M.
    Jones, Kirk D.
    King, Talmadge E., Jr.
    Ryu, Jay H.
    Collard, Harold R.
    THORAX, 2012, 67 (05) : 407 - 411
  • [25] Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity?
    Rodriguez Moncalvo, Juan Jose
    Malet Ruiz, Jose
    Mastroianni, Marcelo
    Khoury, Marina
    Caro, Fabian
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [26] Combination treatment with nintedanib and prednisolone for patients with idiopathic pulmonary fibrosis
    Kato, Motoyasu
    Nakamura, Takahiro
    Kono, Kana
    Haraguchi, Mizuki
    Yamada, Tomoko
    Ihara, Hiroaki
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [27] Treatment Of Idiopathic Pulmonary Fibrosis (ipf) With Laparoscopic Anti-Reflux Surgery (lars) Is Associated With Improvement In Forced Vital Capacity (FVC)
    Raghu, G.
    Mart, D.
    Anstrom, K. J.
    Hinojosa, M.
    Hayes, J.
    Spada, C.
    Oelschlager, B.
    Pellegrini, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [28] Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis
    Takeda, Takayuki
    Kunimatsu, Yusuke
    Tani, Nozomi
    Hashimoto, Izumi
    Kurono, Yuri
    Hirose, Kazuki
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [29] Patients With Idiopathic Pulmonary Fibrosis And Forced Vital Capacity <50% Predicted: Is There A Role For Antifibrotic Therapy?
    Galli, J.
    Pandya, A.
    Dorey-Stein, Z.
    Vega-Olivo, M.
    Criner, G. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [30] Relationship Between MRNA-microRNA Interactions and Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
    Noth, I.
    Roy, J.
    Schmid, R.
    Vinisko, R.
    Strobel, B.
    Neely, M. L.
    Hesslinger, C.
    Belperio, J. A.
    Flaherty, K. R.
    Salisbury, M. L.
    Oldham, J.
    Palmer, S. M.
    Todd, J. L.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345